Amphastar Pharmaceuticals Inc. (AMPH) is a biopharmaceutical company that specializes in the development, marketing, and distribution of generic and proprietary pharmaceutical products. The company's stock has been undergoing technical analysis to assess its performance and potential. Technical analysis involves the examination of various indicators to determine the likely future direction of a stock's price. Several key technical indicators have been used to evaluate AMPH stock.

The relative strength index (RSI) is a widely used indicator that measures the speed and change of price movements. It helps identify overbought or oversold conditions. AMPH stock's RSI has been fluctuating between the overbought and oversold zones, indicating some volatility in its price movements.

Amphastar Pharmaceuticals  (AMPH) Technical Analysis

Learn about the technical analysis indicators for Amphastar Pharmaceuticals Inc (AMPH) stock, including RSI, ADX, MACD, ROC, STOCHRSI, and WILLR. Get insights into the stock's performance and trends. Explore the analysis ratings for AMPH stock.

AMPH Stock Technical Analysis: RSI, ADX, MACD and More

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API). It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation; and Vasopressin to increase blood pressure in adults with vasodilatory shock. Further, the company distributes recombinant human insulin APIs and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Amphastar Pharmaceuticals 

NASDAQ

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	48.10	Neutral	-
auto_graphMACD	-1.79	Neutral	8.6%
auto_graphCCI	71.08	Neutral	-31.4%
auto_graphADX	13.80	Neutral	-
auto_graphATR	3.63	Buy	-
auto_graphWILLR	-28.80	Neutral	-29.6%
auto_graphROC	2.97	Buy	-99.8%
auto_graphSTOCHRSI	99.42	Sell	7.8%

Buy	2	-75.00%
Hold	5	-37.50%
Sell	1	-87.50%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

Amphastar Pharmaceuticals (AMPH) Technical Analysis

Keep an eye on Amphastar Pharmaceuticals

Frequently Asked Questions

What are the technical signals for Amphastar Pharmaceuticals (AMPH) stock based on the last 30 days?

Take Your Investments to a Whole New Level